Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP812407.RALtOc6MnGeTusoAa9I05YF22gu7ynpERzeQTWtgAj154130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP812407.RALtOc6MnGeTusoAa9I05YF22gu7ynpERzeQTWtgAj154130_assertion type Assertion NP812407.RALtOc6MnGeTusoAa9I05YF22gu7ynpERzeQTWtgAj154130_head.
- NP812407.RALtOc6MnGeTusoAa9I05YF22gu7ynpERzeQTWtgAj154130_assertion description "[Prompted by the observation of a marked chronic peripheral neuropathy in a patient suffering from rippling muscle disease due to the R26Q caveolin-3 mutation and because TrkA is expressed by neuronal cells and skeletal muscle fibers, we performed a detailed comparative study on the effect of pathogenic caveolin-3 mutants on the signaling and trafficking of the TrkA nerve growth factor receptor and, for comparison, of the epidermal growth factor receptor.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP812407.RALtOc6MnGeTusoAa9I05YF22gu7ynpERzeQTWtgAj154130_provenance.
- NP812407.RALtOc6MnGeTusoAa9I05YF22gu7ynpERzeQTWtgAj154130_assertion evidence source_evidence_literature NP812407.RALtOc6MnGeTusoAa9I05YF22gu7ynpERzeQTWtgAj154130_provenance.
- NP812407.RALtOc6MnGeTusoAa9I05YF22gu7ynpERzeQTWtgAj154130_assertion SIO_000772 20472890 NP812407.RALtOc6MnGeTusoAa9I05YF22gu7ynpERzeQTWtgAj154130_provenance.
- NP812407.RALtOc6MnGeTusoAa9I05YF22gu7ynpERzeQTWtgAj154130_assertion wasDerivedFrom befree-2016 NP812407.RALtOc6MnGeTusoAa9I05YF22gu7ynpERzeQTWtgAj154130_provenance.
- NP812407.RALtOc6MnGeTusoAa9I05YF22gu7ynpERzeQTWtgAj154130_assertion wasGeneratedBy ECO_0000203 NP812407.RALtOc6MnGeTusoAa9I05YF22gu7ynpERzeQTWtgAj154130_provenance.